Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure

Nicolas Vodovar(Institut Pasteur), Alexandre Mebazaa(Délégation Paris 5), Mark Richards(University of Otago), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), James L. Januzzi(Massachusetts General Hospital), Jane‐Lise Samuel(Université Paris Cité), Johan Lassus(University of Helsinki), Étienne Gayat(Inserm), Alain Cohen‐Solal(Hôpital Lariboisière), Sai͏̈d Laribi(Université de Tours), Damien Logeart(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Semir Nouira(Hospital Fatuma Bourguiba Monastir), Philippe Manivet(Inserm), Riadh Boukef(Délégation Paris 7)
JACC Heart Failure
August 1, 2015
10.1016/j.jchf.2015.03.011
Cited by 89

Related Papers

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
|European Heart Journal|2008|2.7k